Feasibility Study of Novel Prescription Digital Therapeutic Supporting Unobserved Buprenorphine Initiation & Adherence
Not Applicable
Completed
- Conditions
- Opioid Use Disorder
- Interventions
- Device: PEAR-002BDevice: reSET-O
- First Posted Date
- 2022-06-09
- Last Posted Date
- 2023-01-09
- Lead Sponsor
- Pear Therapeutics, Inc.
- Target Recruit Count
- 7
- Registration Number
- NCT05412966
- Locations
- 🇺🇸
Hassman Research Institute, LLC, Berlin, New Jersey, United States
A Remote, Decentralized Opioid Use Disorder Study to Evaluate Patient Engagement With a Game-Based Digital Therapeutic
Not Applicable
Completed
- Conditions
- Opioid-use Disorder
- Interventions
- Device: PEAR-008Device: reSET-O
- First Posted Date
- 2020-09-09
- Last Posted Date
- 2022-12-14
- Lead Sponsor
- Pear Therapeutics, Inc.
- Target Recruit Count
- 52
- Registration Number
- NCT04542642
- Locations
- 🇺🇸
The Substance and Treatment Research Service (STARS) at Columbia University Irving Medical Center and the New York State Psychiatric Institute, New York, New York, United States
🇺🇸Addiction Research and Education Foundation, Gig Harbor, Washington, United States
A Remote, 9-week Insomnia Treatment Trial to Collect Real World Data for a Digital Therapeutic
Not Applicable
Active, not recruiting
- Conditions
- Chronic Insomnia
- Interventions
- Device: PEAR-003A
- First Posted Date
- 2020-03-27
- Last Posted Date
- 2023-02-01
- Lead Sponsor
- Pear Therapeutics, Inc.
- Target Recruit Count
- 1590
- Registration Number
- NCT04325464
- Locations
- 🇺🇸
Pear Therapeutics, Inc., Boston, Massachusetts, United States
© Copyright 2025. All Rights Reserved by MedPath